Phong Phu Pharmaceutical JSC (HNX:PPP)
Vietnam
· Delayed Price · Currency is VND 21,300
0.00 (0.00%)
At close: May 13, 2025
HNX:PPP Ratios and Metrics
Market cap in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | May '25 May 12, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Market Capitalization | 187,440 | 155,760 | 130,240 | 113,520 | 154,880 | 99,440 | Upgrade
|
| Market Cap Growth | - | 19.60% | 14.73% | -26.71% | 55.75% | -38.92% | Upgrade
|
| Enterprise Value | 146,825 | 127,715 | 102,957 | 91,977 | 155,753 | 109,732 | Upgrade
|
| Last Close Price | 21300.00 | 16309.95 | 12780.88 | 10070.29 | 12818.21 | 7812.41 | Upgrade
|
| PE Ratio | 10.71 | 10.02 | 7.18 | 5.51 | 9.17 | 10.13 | Upgrade
|
| PS Ratio | 1.32 | 1.13 | 0.86 | 0.75 | 1.16 | 0.86 | Upgrade
|
| PB Ratio | 1.34 | 1.15 | 1.00 | 0.91 | 1.33 | 0.92 | Upgrade
|
| P/TBV Ratio | 1.53 | 1.31 | 1.15 | 1.07 | 1.59 | 1.13 | Upgrade
|
| P/FCF Ratio | 9.85 | 9.28 | 7.47 | 5.64 | 8.54 | 10.99 | Upgrade
|
| P/OCF Ratio | 9.52 | 8.99 | 5.91 | 5.42 | 8.03 | 9.76 | Upgrade
|
| EV/Sales Ratio | 1.04 | 0.93 | 0.68 | 0.61 | 1.17 | 0.94 | Upgrade
|
| EV/EBITDA Ratio | 5.48 | 5.24 | 3.69 | 2.93 | 6.02 | 5.81 | Upgrade
|
| EV/EBIT Ratio | 6.47 | 6.31 | 4.46 | 3.65 | 7.91 | 8.65 | Upgrade
|
| EV/FCF Ratio | 7.72 | 7.61 | 5.91 | 4.57 | 8.59 | 12.13 | Upgrade
|
| Debt / Equity Ratio | - | - | - | - | 0.02 | 0.10 | Upgrade
|
| Debt / EBITDA Ratio | - | - | - | - | 0.08 | 0.59 | Upgrade
|
| Debt / FCF Ratio | - | - | - | - | 0.11 | 1.23 | Upgrade
|
| Asset Turnover | 0.87 | 0.84 | 0.96 | 0.96 | 0.89 | 0.77 | Upgrade
|
| Inventory Turnover | 2.69 | 2.65 | 3.00 | 2.54 | 2.31 | 2.25 | Upgrade
|
| Quick Ratio | 1.88 | 1.64 | 1.57 | 1.21 | 0.74 | 0.63 | Upgrade
|
| Current Ratio | 3.25 | 2.89 | 2.71 | 2.35 | 1.80 | 1.76 | Upgrade
|
| Return on Equity (ROE) | 14.17% | 13.06% | 15.77% | 17.09% | 15.07% | 9.19% | Upgrade
|
| Return on Assets (ROA) | 8.68% | 7.74% | 9.08% | 10.02% | 8.19% | 5.24% | Upgrade
|
| Return on Capital (ROIC) | 10.43% | 9.53% | 11.33% | 12.95% | 10.37% | 6.53% | Upgrade
|
| Return on Capital Employed (ROCE) | 16.30% | 14.90% | 17.70% | 20.20% | 16.90% | 11.20% | Upgrade
|
| Earnings Yield | 9.32% | 11.14% | 15.43% | 18.16% | 10.91% | 9.87% | Upgrade
|
| FCF Yield | 10.15% | 10.78% | 13.38% | 17.72% | 11.71% | 9.10% | Upgrade
|
| Dividend Yield | 7.50% | 9.20% | 9.39% | 13.90% | - | - | Upgrade
|
| Payout Ratio | 54.12% | 60.16% | 62.02% | 50.08% | 35.37% | 74.62% | Upgrade
|
| Buyback Yield / Dilution | 0.84% | - | 9.83% | 0.34% | 0.72% | -5.58% | Upgrade
|
| Total Shareholder Return | 8.34% | 9.20% | 19.22% | 14.25% | 0.72% | -5.58% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.